Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects.
about
Orexin receptors: pharmacology and therapeutic opportunitiesIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderThe role of orexin in post-stroke inflammation, cognitive decline, and depressionOrexin antagonists for neuropsychiatric disease: progress and potential pitfallsOX1 and OX2 orexin/hypocretin receptor pharmacogeneticsDexamethasone Chemotherapy Does Not Disrupt Orexin SignalingCircadian preference modulates the neural substrate of conflict processing across the dayA key role for orexin in panic anxiety.Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression.LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy.The 1H NMR profile of healthy dog cerebrospinal fluid.Sexually Dimorphic Changes of Hypocretin (Orexin) in DepressionAttenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency.Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight DysregulationModafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleepCerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators.The Neurobiology of Sleep and WakefulnessHypersomnia and depressive symptoms: methodological and clinical aspectsManipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression.Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potentialReward-seeking behavior in human narcolepsyNeural circuit interactions between the dorsal raphe nucleus and the lateral hypothalamus: an experimental and computational study.Motivational activation: a unifying hypothesis of orexin/hypocretin functionDiurnal variation of depressive symptoms.Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day LengthOrexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.Age-related changes in sleep and circadian rhythms: impact on cognitive performance and underlying neuroanatomical networks.Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions.The effect of clomipramine on wake/sleep and orexinergic expression in rats.Orexin, stress, and anxiety/panic states.Subchronical treatment with Fluoxetine modifies the activity of the MCHergic and hypocretinergic systems. Evidences from peptide CSF concentration and gene expressionCircadian rhythms and sleep--the metabolic connection.Emerging drugs for panic disorder.Role of orexin in the pathophysiology of depression: potential for pharmacological intervention.The hypocretin system and psychiatric disorders.Hypocretin (orexin) regulation of sleep-to-wake transitions.The hypocretin/orexin system: an increasingly important role in neuropsychiatry.Novel investigational therapeutics for panic disorder.Interactions of the histamine and hypocretin systems in CNS disorders.
P2860
Q24597418-4F9F8EC7-FE59-491F-95BD-71486DA482ACQ26747511-A9968BED-F972-4754-9DD0-E09C523672F4Q26851982-0FCC62D1-EE7A-41F8-8B3E-A62515F5638BQ26852653-AAD729A4-100F-474E-BB1A-EEA30A3C7AA2Q26865384-06456C58-DA86-497A-8CBD-C54C6447441DQ28555144-228408F9-1C63-4D35-8176-A8AB705B473CQ28740360-7E184BDE-C0F8-4A4D-BE0D-667099F122EDQ30480814-60AA3EAC-44AE-4691-A10F-5B02A60A81B7Q30524245-3483D69B-CA69-4548-881D-A9DB969E3532Q30569599-1A2FAABE-8802-4399-95A0-82BEF636BA8AQ31146776-67210ADF-D40D-44F9-A127-15EB7A40951CQ33603710-B39E0517-ABFD-42A7-AD36-A941C51908C5Q33875477-9D3304A8-C046-46EF-BC67-245C7B887EA0Q33887434-6B4C9E1C-A233-4D8B-BF2A-8CBF9A8E1AE1Q34130020-FF03815B-C362-4B4F-8ABD-1E66AAD6EF24Q34344331-35D86708-96AC-4206-BF3D-31C84FDB1ED9Q34439846-526F585D-DE4F-4B40-8D09-1468414CD858Q34502802-4F8DF481-D461-448F-B672-CEF8DDE17A5BQ34628648-E71625BA-7A09-41BB-A70F-E23C71D1A988Q34632470-09CBCD8A-7B96-4215-BA15-F5C501ABD4FBQ34660915-2750CA33-5516-4FF0-A9FD-0F599D9D991AQ35042283-EC340A11-CA8E-4993-BF1D-5E7671DDF0C6Q35091506-2CDE54E7-E435-480D-8EA4-AE145DBB731FQ35105241-7E9561E2-EBFD-4E32-B595-2C1E00002843Q35237023-E47C4488-2FB1-418C-96EB-A03B4563C566Q35967844-6B917C3F-425B-4DB5-9DA8-95D582CB46C4Q36018973-7A4A5064-8D6C-4898-B849-6449903AF900Q36118144-4DBF4728-35A5-4678-B56F-077ABAE54EECQ36553056-61347F30-640C-4AC0-8D1F-9E5FBDBD453AQ36587873-B6E25318-5E9C-4752-BB87-FABC0F760389Q36880278-F3CC7295-5C5C-4125-8820-0AC72B07B3CFQ37254336-1873BDB5-118C-4332-A089-9C720479F777Q37895167-CD647527-A4A3-43CC-8CF5-13355466A187Q37945699-253CD8DE-4710-4F42-AD30-1ED2523EE7E1Q38105280-053FD199-4880-4C8F-849E-D93CBD1BE926Q38173326-9129A6E8-0404-4FBA-896C-1E60CDFC9A4CQ38191600-0D211EDC-3559-46C8-A986-7782CDA0ED48Q38231949-B16BF030-8DA5-428C-8D64-3DE70C2D3544Q38300166-7D84A0FF-94B9-4277-951E-83D94CC271D3Q38534913-1A311C85-EBF5-444C-813F-B1E6A61EFFD9
P2860
Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Diurnal variation of cerebrosp ...... ontrol and depressed subjects.
@en
Diurnal variation of cerebrospinal fluid hypocretin-1
@nl
type
label
Diurnal variation of cerebrosp ...... ontrol and depressed subjects.
@en
Diurnal variation of cerebrospinal fluid hypocretin-1
@nl
prefLabel
Diurnal variation of cerebrosp ...... ontrol and depressed subjects.
@en
Diurnal variation of cerebrospinal fluid hypocretin-1
@nl
P2093
P1476
Diurnal variation of cerebrosp ...... ontrol and depressed subjects.
@en
P2093
Benjamin Johnson
Beth Ripley
Dennis Schmidt
John S Kennedy
Ronald M Salomon
Seiji Nishino
P304
P356
10.1016/S0006-3223(02)01740-7
P407
P577
2003-07-01T00:00:00Z